Sense Biodetection
Eli Nabavi is a seasoned professional in the biomedical field with extensive experience in research and development across various organizations. Currently serving as Chief Executive Officer at SemiMed since September 2023, Eli also holds roles as Principal Scientist at Sherlock Biosciences, Lead Scientist in Process Development at Sense Biodetection Ltd., and Clinical Development Engineer at CMR Surgical, all since April 2022. Previous positions include Senior Research Associate/Physicist at University College London from August 2017 to February 2021, and a similar role at King's College University where Eli specialized in optical imaging technologies for minimally invasive diagnosis and surgery. Additional experience includes serving as Senior Physicist at neoLAB and as Research Associate at the Hamlyn Centre, Imperial College London. Eli's expertise encompasses translational research and the ethical considerations necessary for integrating optical imaging techniques into clinical settings.
This person is not in any offices
Sense Biodetection
Sense Biodetection provides diagnostic technologies that deliver incredibly fast, accurate results, are easy for clinicians to master, and offer the flexibility to run one test or dozens at the same time.